Vincenti, F <br/><br/>
A phase I/II randomized open-label multicenter trial of efalizumab, a humanized anti-CD11a, anti-LFA-1 in renal transplantation.  [electronic resource] 

 -  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons  Jul 2007 
 - 1770-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1600-6135 
<br/><br/><label>Standard No.: </label>10.1111/j.1600-6143.2007.01845.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--administration & dosage<br/>Antibodies, Monoclonal, Humanized<br/>Antigens, CD--immunology<br/>CD11a Antigen--immunology<br/>Drug Administration Schedule<br/>Graft Rejection--epidemiology<br/>Humans<br/>Injections, Subcutaneous<br/>Kidney Transplantation--immunology<br/>Living Donors<br/>Lymphocyte Function-Associated Antigen-1--immunology<br/>Psoriasis--chemically induced